MAP2K1 and colonic neoplasm: In colon cancer, resistance to MEK inhibitors, often can be due to the presence of specific mutations such as V211D in MEK1.524 Moreover, the C121S mutations in MEK1 lead to abnormal kinase activity compared to the wild type.